Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Cingulate Inc ( (CING) ) is now available.
Cingulate Inc. announced that as of December 15, 2025, Shane Schaffer has been reinstated as Chief Executive Officer after being placed on administrative leave due to a personal legal matter. The board of directors had previously appointed John A. Roberts as Executive Chairman and Jennifer Callahan as interim CEO during Schaffer’s leave. With Schaffer’s return, Roberts will continue as Chairman and Callahan will remain as CFO. The company also amended Schaffer’s employment agreement, adjusting terms related to termination and salary.
The most recent analyst rating on (CING) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Cingulate Inc stock, see the CING Stock Forecast page.
Spark’s Take on CING Stock
According to Spark, TipRanks’ AI Analyst, CING is a Neutral.
Cingulate Inc.’s overall stock score is primarily impacted by its poor financial performance, with persistent losses and negative cash flows. However, recent corporate developments, such as securing a grant and progress towards FDA approval, provide a positive outlook. The technical analysis shows neutral momentum, but valuation remains a concern due to financial losses and lack of dividends.
To see Spark’s full report on CING stock, click here.
More about Cingulate Inc
Average Trading Volume: 181,594
Technical Sentiment Signal: Hold
Current Market Cap: $30M
Learn more about CING stock on TipRanks’ Stock Analysis page.